Neogenomics Inc (NASDAQ:NEO)

7.52
Delayed Data
As of Feb 16
 -0.08 / -1.05%
Today’s Change
7.08
Today|||52-Week Range
11.63
-15.12%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close7.60
Today’s open7.56
Day’s range7.44 - 7.74
Volume234,103
Average volume (3 months)387,765
Market cap$604.7M
Data as of 3:59pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)-20.74%
Earnings growth (next 5 years)+29.70%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc-0.14-1.49%
ENZEnzo Biochem Inc-0.09-1.29%
KANGiKang Healthcare Gro...-0.11-0.68%
RDNTRadNet Inc+0.05+0.50%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts